Entera Bio (ENTX)
(Delayed Data from NSDQ)
$1.80 USD
0.00 (0.00%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Entera Bio Ltd. has a market cap of $82.19M, which represents its share price of $1.80 multiplied by its outstanding shares number of 45.66M. As a small-cap company, ENTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ENTX 1.80 0.00(0.00%)
Will ENTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ENTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENTX
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates
ENTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Argenx (ARGX) This Year?
ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
Other News for ENTX
Stochastic Buy Signal appears for ENTX after 0.0% move
Technical picture remains unchanged for ENTX after it rises 1.69% on September 18
ENTX's price falls by 2.75% on September 18, though its technical setup remains stable.
Technical picture remains unchanged for ENTX after it falls 0.55% on September 16
Technical picture remains unchanged for ENTX after it rises 1.67% on September 15